On December 31, 2007, Regeneron Pharmaceuticals (REGN) had a market capitalization of $1.9B, based on 78.49M shares at a price of $24.05.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2007 | $24.05 | 12,706,300 | 78,493,000 | $1,887,513,321.70 |
November 2007 | $21.69 | 16,213,100 | 78,493,000 | $1,702,277,691.00 |
October 2007 | $21.91 | 15,354,300 | 78,493,000 | $1,719,475,507.30 |
September 2007 | $17.72 | 13,533,100 | 66,069,000 | $1,171,006,956.00 |
August 2007 | $19.38 | 24,471,500 | 66,069,000 | $1,280,212,406.10 |
July 2007 | $14.83 | 13,226,800 | 66,069,000 | $979,565,421.60 |
June 2007 | $17.84 | 28,420,800 | 65,950,000 | $1,176,778,825.00 |
May 2007 | $22.34 | 22,373,600 | 65,950,000 | $1,473,599,990.00 |
April 2007 | $27.08 | 16,149,100 | 65,950,000 | $1,786,183,205.00 |
March 2007 | $21.53 | 15,081,600 | 65,563,000 | $1,411,420,595.10 |
February 2007 | $19.76 | 12,044,600 | 65,563,000 | $1,295,216,733.90 |
January 2007 | $19.81 | 9,997,800 | 65,563,000 | $1,298,481,771.30 |
December 2006 | $19.98 | 9,467,700 | 65,563,000 | $1,310,230,660.90 |
November 2006 | $21.42 | 15,985,700 | 65,563,000 | $1,404,241,446.60 |
October 2006 | $19.96 | 8,928,400 | 65,563,000 | $1,308,925,957.20 |
September 2006 | $15.62 | 7,414,300 | 57,011,000 | $890,682,853.00 |
August 2006 | $15.81 | 5,288,900 | 57,011,000 | $901,469,334.20 |
July 2006 | $13.60 | 6,587,200 | 57,011,000 | $775,446,518.70 |
June 2006 | $12.77 | 8,271,100 | 56,915,000 | $726,537,049.50 |
May 2006 | $12.88 | 9,250,700 | 56,915,000 | $733,338,392.00 |
April 2006 | $14.46 | 7,189,000 | 56,915,000 | $822,877,070.00 |
March 2006 | $16.56 | 8,385,800 | 56,727,000 | $939,342,393.00 |
February 2006 | $16.30 | 8,207,600 | 56,727,000 | $924,655,772.70 |
January 2006 | $15.17 | 11,015,500 | 56,727,000 | $860,264,955.00 |
December 2005 | $15.83 | 11,594,900 | 56,727,000 | $898,107,536.70 |
